McLeod Ian

SVP, CAO & TreasurerAnika Therapeutics, Inc. (ANIK) · full profile →Form 4 · filed Mar 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 19, 2026Grant(A)18K$018K
Mar 19, 2026Grant(A)13K$013K
Mar 19, 2026Grant(A)11K$011K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-120005) within minutes of acceptance. Every field above traces to the original document. Verify it directly: